Yazar "Ketenci, Sertac" seçeneğine göre listele
Listeleniyor 1 - 4 / 4
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Are These Truly Rheumatoid Arthritis or Antisynthetase Syndrome Cases?(Turkish League Against Rheumatism, 2019) Ketenci, Sertac; Salbas, Ender[Abstract Not Available]Öğe Infodemiology of Bell's palsy: Tracing the seasonality of facial paralysis(Ios Press, 2022) Salbas, Ender; Ketenci, SertacBACKGROUND: Although there are a few studies on the seasonality of facial paralysis, no studies have utilized internet data for this purpose. The use of internet data to investigate diseases and user-contributed health-related content is increasingly prevalent, and has earned the name infodemiology. OBJECTIVE: This study aims to use Google Trends data to investigate whether there is a seasonal variation in facial paralysis. METHODS: In this observational study, the search volume for the terms facial paralysis and Bell's palsy for a total of 19 countries was queried from Google Trends, selecting the time interval between January 2004 and October 2020. RESULTS: In the Cosinor analysis of data from a total of 19 countries, from both northern and southern hemisphere, a statistically significant seasonality was found in the search volume of facial paralysis. It was observed that facial paralysis searches peaked in spring in the northern hemisphere and in winter in the southern hemisphere. CONCLUSION: Internet search query data showed that facial paralysis has a seasonal variation, with peaks in spring for the northern hemisphere and winter for the southern hemisphere. Further studies are needed to understand the deviation between hemispheres and the cause of the peak in winter-spring season.Öğe Pyoderma gangrenosum associated with Behcet's disease(Turkish League Against Rheumatism, 2021) Ketenci, Sertac; Salbas, Ender[Abstract Not Available]Öğe The attitudes of Turkish physicians in the treatment of fibromyalgia; is Pregabalinophobia the new reality of pain medicine?(Kare Publ, 2022) Ketenci, Sertac; Golboyu, Birzat Emre; Salbas, Ender; Uzuner, Bora; Ciftci, BahadirObjectives: This study aims to determine the treatment preferences of physicians interested in fibromyalgia treatment and to investigate their hesitations about prescribing pregabalin. Methods: Our survey study was conducted between February 5 and 20, 2021. The survey forms were sent to the known email addresses and phone numbers of 1569 physical medicine and rehabilitation (PMR), algology, and rheumatology physicians. The replies to the surveys were checked for possible resubmissions. The pooled data were evaluated with the SPSS 22.0 statistical package program. Frequency distributions were calculated and presented as n, %. Results: Four hundred and six PMR, rheumatology, and algology specialists fulfilled the study forms. About 59.0% of physicians stated that they prefer duloxetine as the first-line agent of fibromyalgia syndrome (FMS) treatment. Pregabalin was only 6.0% of the physicians' first choice for FMS. About 35.0% of the participating physicians stated that the PMR department should follow up FMS patients. About 44.3% of the participants noted that they refer FMS patients to other departments which interested in FMS treatment and do not want to follow-up FMS patients. About 81% agreed that pregabalin causes addiction. About 36.7% stated that at least 20% of the patients could abuse pregabalin and 97.8% of physicians stated that they were prejudiced about prescribing pregabalin to prisoners. Approximately two of the three physicians experienced an act of violence in their hospital regarding pregabalin prescribing. Conclusion: These data showed that the Pregabalinophobia should be accepted. This condition is associated with life safety concerns of the physician not only from unreliability of the drug. It seems that the doctors have valid reasons to develop this prejudice.
